The Citrini Report is a super-optimistic report. A close look at <a href="https://oninvest.com/article/obval-akcij-na-38-i-vvp-prizrak-o-cem-govoritsa-v-virusnom-otcete-o-budusem-s-ii">this text</a> shows that its authors believe in the omnipotence of artificial intelligence much more than all the AI analysts in the Trump administration: if the Trump administration were so confident in the omnipotence of AI, they would only think about regulating it, according to AI researcher <a href="https://www.facebook.com/mikaelalemu251">Mikael Gorsky</a>.

Should we be worried about the fate of the world: three reasons to ignore the Citrini report

Stellantis N.V.

The auto industry's financial losses due to the winding down of investments in electric vehicle projects have exceeded $50 billion in recent months, The Wall Street Journal has estimated

The maker of Jeep and Fiat ended the year with a loss for the first time in history due to electric cars

Bajaj Consumer Care Limited

MTAR Technologies Limited

MRV Engenharia e Participacoes S.A.

Last year showed that small caps in emerging markets can compete with large issuers, despite a <a href="https://en.oninvest.com/article/undervalued-small-caps-where-to-make-money-in-emerging-markets">lag</a>&nbsp;that persisted through the third quarter. For 2025, the return of the Equal Weight EM Small Cap Index, put together by analyst Aldiyar Anuarbekov for Oninvest, amounted to 18.25% in dollar terms*. For comparison: the broad-market S&amp;P 500 index grew 16.65%, while the smid-cap Russell 2000 rose 11.21% last year. The 8.06% increase in the Cap Weight EM Small Cap Index, meanwhile, indicates that the gains were more evenly distributed rather than concentrated in a small number of large stocks.

Where to find outstripping returns in EM small caps in 2026

Dutch Bros Inc.

Dutch Bros, a small U.S. coffee chain, is a growth stock that "could supercharge your returns over the next five years and beyond," <a href="https://www.fool.com/investing/2026/02/26/growth-stock-supercharge-invest-return-5-years/">argues</a>&nbsp;Motley Fool contributing analyst Neil Patel. The company’s stock is trading about 45% below its peak even as its fundamentals remain strong, he says, creating an attractive entry point for investors.

Motley Fool analyst likes growing U.S. coffee chain Dutch Bros on dip

VolitionRx Limited

Shares of VolitionRx, a micro-cap developer of blood tests for cancer and sepsis, <a href="https://finance.yahoo.com/quote/VNRX/">jumped</a>&nbsp;nearly 26% on Tuesday after the company <a href="https://ir.volition.com/news-events/press-releases/detail/874/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution">reported</a>&nbsp;progress in several research programs and said a newly developed cancer-detection method has attracted interest from potential partners. The company also highlighted breakthrough research on detecting lymphoma in cats. Wall Street analysts <a href="https://www.marketwatch.com/investing/stock/vnrx/analystestimates?mod=mw_quote_tab">say</a>&nbsp;the stock could have nearly 790% upside.

Cancer blood test maker VolitionRX soars 25% in a day on reported commercial progress

NVIDIA Corporation

Salesforce, Inc.

IonQ, Inc.

Nutanix, Inc.

Synopsys, Inc.

Advanced Micro Devices, Inc.

The Trade Desk, Inc.

Warner Bros. Discovery, Inc.

Paramount Skydance Corporation

Netflix, Inc.

Thomson Reuters Corporation

United Therapeutics Corporation

Circle Internet Group

Clear Secure, Inc.

Jazz Pharmaceuticals plc

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

New York morning: markets assess Nvidia report and look for new drivers

What are analysts saying about the results of one of the AI race leaders and what to expect from it next?

'The extraordinary seems ordinary': why Wall Street has embraced Nvidia's report without enthusiasm

Paramount's quarterly loss jumped 2.5 times amid falling revenue from TV networks

Revenue at Paramount's only profitable business has plummeted. Will its purchase by Warner save it?

Deckers Outdoor Corporation

Henry Schein, Inc.

HP Inc.

Victoria's Secret & Co.

David Einhorn, the founder of hedge fund Greenlight Capital, seriously <a href="https://www.sec.gov/Archives/edgar/data/1489933/0001172661-26-001122-index.html">revamped</a> his portfolio last quarter, almost completely getting rid of HP securities in favor of companies from the industrial sector and media business. The most notable deal was the purchase of shares of Warner Bros. Discovery. Over the past quarter, the value of the fund's public portfolio <a href="https://seekingalpha.com/article/4853256-tracking-david-einhorns-greenlight-capital-portfolio-q3-2025-update">grew by </a>12% to $2.85 billion.

Movies, running and AI skepticism: what the investor who predicted Lehman's collapse changed in his portfolio

Salesforce will target $50 billion to buy back its shares from the market, deeming its current price low

Salesforce earnings beat expectations, but the stock fell 5%. What spooked investors?

Amazon.com, Inc.

Nvidia reported record revenue of $68.1 billion last quarter thanks to the data center boom and forecasts up to $79.6 billion for the current period. The company finally received a U.S. license for limited shipments of its H200 artificial intelligence chips to China. And Amazon is discussing a major investment in developer ChatGPT. These and other topics - in the review of key events for the morning of February 26.

Top story for the morning: Nvidia beats forecasts, Amazon prepares up to $50 billion for OpenAI

Eli Lilly and Company

Novo Nordisk A/S

JPMorgan, Deutsche Bank and RBC Capital believe that pharmaceutical company Eli Lilly will be the main beneficiary of the rapidly growing market of GLP-1 weight loss drugs. Analysts point to the higher efficacy of its therapy compared to competitors, development of direct sales and potential expansion of insurance coverage.

Retail